Literature DB >> 10228929

The Iowa Personality Disorder Screen: development and preliminary validation of a brief screening interview.

D R Langbehn1, B M Pfohl, S Reynolds, L A Clark, M Battaglia, L Bellodi, R Cadoret, W Grove, P Pilkonis, P Links.   

Abstract

The length and expense of comprehensive personality disorder interviews makes them unwieldy for routine use. A brief but sensitive screen could eliminate administration of longer instruments in many instances. We describe the development of the Iowa Personality Disorder Screen (IPDS)--a mini-structured interview which can be completed in less than 5 minutes. Retrospective analyses using 1,203 SIDP-R interviews suggested that the IPDS items should provide good sensitivity and specificity. We present results from a prospective validation study, using a mixed group of 52 nonpsychotic inpatients and outpatients who were diagnosed using the SIDP-IV. Blind administration of the IPDS yielded excellent sensitivity (92%) and good specificity (79%), using a subset of five screening items. Addition of two more items leads to an estimated sensitivity of 79% and specificity of 86%. The IPDS shows promise as a quick personality disorder screen for use in research settings or standard clinical interviews.

Mesh:

Year:  1999        PMID: 10228929     DOI: 10.1521/pedi.1999.13.1.75

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  25 in total

1.  The Relationship Between Problem Gambling and Attention Deficit Hyperactivity Disorder.

Authors:  O R Waluk; G J Youssef; N A Dowling
Journal:  J Gambl Stud       Date:  2016-06

2.  Screening for personality disorders.

Authors:  Jennifer Q Morse; Paul A Pilkonis
Journal:  J Pers Disord       Date:  2007-04

3.  Lifestyle and social network in individuals with high level of social phobia/anxiety symptoms: a community-based study.

Authors:  Christian A Falk Dahl; Alv A Dahl
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-26       Impact factor: 4.328

4.  Personality disorder: a new global perspective.

Authors:  Peter Tyrer; Roger Mulder; Mike Crawford; Giles Newton-Howes; Erik Simonsen; David Ndetei; Nestor Koldobsky; Andrea Fossati; Joseph Mbatia; Barbara Barrett
Journal:  World Psychiatry       Date:  2010-02       Impact factor: 49.548

5.  An Empirical Study of Personality Disorders Among Treatment-Seeking Problem Gamblers.

Authors:  M Brown; E Oldenhof; J S Allen; N A Dowling
Journal:  J Gambl Stud       Date:  2016-12

Review 6.  Personality Pathology in Primary Care: Ongoing Needs for Detection and Intervention.

Authors:  Steven K Huprich
Journal:  J Clin Psychol Med Settings       Date:  2018-03

7.  Conventional and unconventional treatments for stress among methadone-maintained patients: treatment willingness and perceived efficacy.

Authors:  Declan T Barry; Mark Beitel; Timothy Breuer; Christopher J Cutter; Jonathan Savant; Richard S Schottenfeld; Bruce J Rounsaville
Journal:  Am J Addict       Date:  2010-12-28

8.  Assessing personality disorders in a national mental health survey.

Authors:  Terry J Lewin; Tim Slade; Gavin Andrews; Vaughan J Carr; Charles W Hornabrook
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-02       Impact factor: 4.328

9.  Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications.

Authors:  Gholson J Lyon; Tao Jiang; Richard Van Wijk; Wei Wang; Paul Mark Bodily; Jinchuan Xing; Lifeng Tian; Reid J Robison; Mark Clement; Yang Lin; Peng Zhang; Ying Liu; Barry Moore; Joseph T Glessner; Josephine Elia; Fred Reimherr; Wouter W van Solinge; Mark Yandell; Hakon Hakonarson; Jun Wang; William Evan Johnson; Zhi Wei; Kai Wang
Journal:  Discov Med       Date:  2011-07       Impact factor: 2.970

10.  Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients.

Authors:  Declan T Barry; Mark Beitel; Brian Garnet; Dipa Joshi; Andrew Rosenblum; Richard S Schottenfeld
Journal:  J Clin Psychiatry       Date:  2009-07-14       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.